Closed Fracture of Hip Clinical Trial
Official title:
Effect of General and Regional Anesthesia on Fracture Healing
Investigator' s study designed to investigate effect of general and regional anesthesia on
fracture healing.The 40 age and older ASAI-III patients who will operate due to femur
fracture (except femur neck fracture) will be enrolled in this study after informed consent
approval.
Subjects will be divided into two groups by a computerized randomization method. 40 patients
will be enrolled in this study. General anesthesia will perform for 20 patients. Regional
anesthesia will perform for 20 patients. Preoperative, 4. week and 12. weeks laboratory test
which include blood and urine β-C terminal telopeptid (β-CTX), blood alkaline phosphatase and
osteocalcin will test for all patients. All patients will not use nonsteroid
anti-inflammatory drugs during study neither perioperative nor postoperative periods.
fracture healing will be asses with clinical evaluation and laboratory tests.
Investigator' s study designed to investigate effect of general and regional anesthesia on
fracture healing.The 40 age and older ASAI-III patients who will operate due to femur
fracture (except femur neck fracture) will be enrolled in this study after informed consent
approval.
Subjects will be divided into two groups by a computerized randomization method. 40 patients
will be enrolled in this study. Each group will have 20 patients. However a pilot study will
perform for each groups with 10 patients. In Group G, all patients will be applied general
anesthesia and 2 mg/kg propofol and 0,6 mg/kg rocuronium will administer to patients for
induction of anesthesia. Maintenance of anesthesia will be made with %50-%50 O2/N2O and %2
sevoflurane. 0,1 mg/kg morphine will be held on last 10 minutes of operation for
postoperative analgesia. Also, patient controlled analgesia with morphine(1 mg bolus and 20
min lockout time) will apply for postoperative analgesia. If it is necessary additional
analgesic will provide with 100 mg peroral and intravenous tramadol. Regional anesthesia will
perform for 20 patients which named Group R. In Group R combined epidural-spinal anesthesia
will perform. Spinal %5 bupivacain 15 mg and 20µg fentanyl will apply and analgesia will
provide with epidural bupivacain. Preoperative, 4. week and 12. weeks laboratory test which
include blood and urine β-C terminal telopeptid (β-CTX), blood alkaline phosphatase and
osteocalcin will all patients. All patients will not use nonsteroid antiinflammatory drugs
during study neither perioperative nor postoperative periods. Fracture healing will be asses
with clinical evaluation and laboratory tests. All measurements will be assessed with
statistically.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Not yet recruiting |
NCT01326403 -
Tranexamic Acid in Hip Fracture Patients
|
N/A | |
Completed |
NCT01473082 -
Proximal Femoral Nail Antirotation (PFNA) Versus PFNA Augmentation
|
Phase 4 |